Yuyu Pharma Inc Cash Flow-to-Debt Ratio
Yuyu Pharma Inc cash flow-to-debt ratio. Yuyu Pharma Inc (000227) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of ₩836.62 Million could theoretically repay 0% of its total liabilities (₩63.32 Billion) in one year. Check Yuyu Pharma Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Yuyu Pharma Inc (2014–2024)
Cash flow-to-debt ratio of Yuyu Pharma Inc from 2014 to 2024. Historical debt coverage capacity for Yuyu Pharma Inc across 11 annual periods. Check Yuyu Pharma Inc (000227) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Yuyu Pharma Inc Cash Flow-to-Debt Ratio by Year (2014–2024)
Yuyu Pharma Inc cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for Yuyu Pharma Inc. For the full cash flow conversion analysis, see cash flow conversion of Yuyu Pharma Inc.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.34x | ₩24.95 Billion | ₩72.62 Billion | ▲ +6255.6% |
| 2023 | 0.01x | ₩420.86 Million | ₩77.86 Billion | ▲ +106.2% |
| 2022 | -0.09x | ₩-6.23 Billion | ₩71.83 Billion | ▼ -223.7% |
| 2021 | 0.07x | ₩4.51 Billion | ₩64.30 Billion | ▲ +199.5% |
| 2020 | -0.07x | ₩-2.67 Billion | ₩37.86 Billion | ▼ -125.2% |
| 2019 | 0.28x | ₩13.19 Billion | ₩47.17 Billion | ▲ +121.2% |
| 2018 | 0.13x | ₩6.11 Billion | ₩48.35 Billion | ▲ +770.2% |
| 2017 | 0.01x | ₩561.35 Million | ₩38.66 Billion | ▼ -95.1% |
| 2016 | 0.30x | ₩9.82 Billion | ₩33.01 Billion | ▲ +177.9% |
| 2015 | -0.38x | ₩-11.68 Billion | ₩30.60 Billion | ▼ -937.8% |
| 2014 | 0.05x | ₩1.36 Billion | ₩29.91 Billion | — |